External Funding Opportunities

Funding Opportunity

Deadline

NIH Notice of Special Interest (NOSI): Research Supplements to Promote Re-Entry and Re-integration into Health-Related Research Careers (Admin Supp) Deadline: On-going starting August 26

Ongoing

NIH Notice of Special Interest (NOSI): Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy  The overall goal of this Notice of Special Interest (NOSI) is to promote mechanistic research aimed at better understanding the pathophysiology of immune-related adverse events (irAEs). It is anticipated that the mechanistic research supported through this NOSI will build the foundational knowledge which will ultimately lead to better strategies to predict, prevent and/or ameliorate toxicities that can arise as a consequence of current immunotherapeutic regimens, and improve treatment outcomes. The proposed research can be basic or translational but should be focused on revealing the mechanisms underlying irAEs. Deadline: On-going

 Ongoing

NIH Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01)

May 17

HHS-NCI Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Stimulate or Strengthen Global Cancer Health Disparities Research

May 25

NIH Risk and Protective Factors of Family Health and Family Level Interventions (R01) 

June 5

NIH Focused Technology Research and Development (R01)

June 5

NIH-NCI Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer  The purpose of this Notice of Special Interest (NOSI) is to promote research in understanding the mechanisms by which cannabis and cannabinoids affect cancer biology, cancer interception, cancer treatment and resistance, and management of cancer symptoms.

June 5

NIH Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE)  The purpose of this FOA is to solicit research projects utilizing state-of-the-art cancer biology methods and model systems to study effects of different types of radiation used in radionuclide-based therapeutics (e.g., radiopharmaceutical therapy) on normal tissue, tumor cells and the tumor microenvironment.

  • R01 Deadline: June 5
  • R21  Deadline: June 16
Varies

 NIH Exploratory Grants in Cancer Control (R21)

June 7

NIH Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)

June 14

NIH Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)

June 14

NIH Dissemination and Implementation Research in Health  The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.

  • R01 Deadline: June 15
  • R21 Deadline: June 16
  • R03 Deadline: June 16
Varies

NIH Technology Development Research for Establishing Feasibility and Proof of Concept (R21) 

June 16

NIH Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01)

June 17

NIH Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery  This FOA invites research projects that seek to explain the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in human health, illness, recovery, and overall wellbeing.

 June 21

NIH Education Program on Translational Devices (R25)

July 29

NIH Microbial-based Cancer Imaging and Therapy - Bugs as Drugs  This Funding Opportunity Announcement (FOA) solicits grant applications proposing to utilize bacteria, archaebacteria, bacteriophages, or other non-oncolytic viruses and their natural products to study the underlying mechanisms of the complex interactions between microorganisms, tumors, and the immune system, and to explore their clinical potential for cancer imaging, therapeutics or diagnostics. Projects can focus on using microorganisms as anti-tumor agents, as activators of anti-tumor immunity, or as delivery vehicles for treatment, diagnosis, or imaging, complementing or synergizing with existing tools and approaches.

  • R01 Deadline: June 5
  • R21 Deadline: June 16

 Varies

NIH Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01)  The purpose of this FOA is to support studies that aim to better understand and/or address survivorship needs for individuals living with likely incurable cancer. This group is heterogenous in terms of cancer type, treatments received, prognosis, and outcomes. Specifically, this RFA is intended to solicit applications proposing 1) observational studies to understand the trajectory of physical and psychological symptoms, patterns of care, and unmet needs; and/or 2) the development and testing of interventions to improve the delivery of comprehensive survivorship care in this group of cancer survivors

September 30

NIH Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity  The purpose of this Notice of Special Interest (NOSI) is to encourage collaborative and innovative approaches to mitigate cardiovascular dysfunction while optimizing cancer outcomes by understanding the mechanisms of cancer treatment-related cardiotoxicity and translating the findings to improve risk stratification, early detection, prevention, and management. Deadline: Depends on target FOA

 Varies

NIH Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards  The overarching goal of this pilot program is to enhance the retention of investigators facing critical life events who are transitioning to the first renewal of their first independent research project grant award or to a second new NIH research project grant award. Retention at the first renewal or continuous NIH research project grant support is crucial for sustaining both the ongoing research NIH has made an investment in and for retaining diversity in the biomedical research workforce. Deadline:  Varies by awarding IC

 Varies

NIH Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers  The purpose of this Notice of Special Interest (NOSI) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals. Research efforts that identify specific contributions of HIV infection and its potential interaction with other pathogens towards the development and pathogenesis of these cancers and provide information on the clinical outcomes of such cancers in the HIV-infected population are sought.  Deadline:  Applies to due dates on or after May 7, 2020 through January 8, 2023

 Varies

NIH Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications  The purpose of this NOSI is to encouraging new applications to advance research activities relevant to synthetic biology.  The overarching goal(s) of this Notice are to: 1) develop tools and technologies to control and reprogram biological systems; 2) apply synthetic biology approaches for the development of biomedical technologies; 3) increase the fundamental understanding of synthetic biology concepts as they relate to human health; and 4) gain fundamental biological knowledge through the application of synthetic biology approaches. Deadline: Varies by IC

 Varies

NIH Research Supplements to Promote Diversity in Health-Related Research  The NIH and the CDC hereby notify PD(s)/PI(s) holding specific types of research grants  that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project.  Administrative supplements must support work within the scope of the original project. Deadline: Varies by awarding IC

 Varies

NIH Notice of Special Interest (NOSI): Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes  The purpose of this NOSI is to solicit investigator-initiated applications that aim to better understand the effects of a cancer diagnosis and subsequent cancer treatment on aging trajectories and aging outcomes. Applications for this initiative should submit through funding opportunity announcements (FOAs) or any reissues of these announcements as noted in this notice.

Varies

NIH Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health 

Varies

NIH-NCI Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology  The purpose of this Notice of Special Interest (NOSI) is to stimulate research on the role of RNA modifications in the area of cancer biology. Despite the recognition that RNA modifications and editing exert substantial impact on gene expression and function, there are a lack of mechanistic insights into the dynamic regulation of RNA modifications and how their de-regulation drives cancer formation. A better understanding of the extent, diversity and crosstalk between different types of RNA modification, and the elucidation of the molecular players that read and interpret the modification code are needed to reveal the mechanisms of RNA modifications that underly cancer formation and the cancer phenotype. Deadline: Varies by activity code

 Varies

NIH Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan  This NOSI encourages highly innovative translational research focused on the delivery of multilevel interventions to improve uptake of evidence-based screening services that promote health equity and that are recommended by expert committees (e.g., the USPSTF, CPSTF, AAP, ACOG). Multilevel interventions are one tool to reduce health disparities and promote health equity because they address the dynamic interplay of multiple levels of socioecological influence, including those at the individual, interpersonal, family, organizational, neighborhood, community, and societal levels.

Varies by institute

Funding Opportunity

Deadline

Mark Foundation for Cancer Research Emerging Leader Awards  These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio. Applicants must be three to nine years from the start of an independent faculty research appointment as of December 31, 2022. Projects for this award must be centered on evidence-based laboratory, data, and/or medical science. Proposed projects must not be supported by other sources of funding. Deadline: May 2

 May 7

Mark Foundation Endeavor Award  The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts. Webinars are available for additional details. Deadlines: July 13 – LOI; December – Full applications due by invite

 July 13

NSF Division of Molecular and Cellular Biosciences: Investigator-initiated research projects (MCB)  

On-going

DOE-JGI CSP New Investigator 

On-going

NSF Big Ideas updates

Varies

DOD-CDMRP Breast Cancer Research Program (BCRP)  The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP seeks to accelerate high-impact research with clinical relevance, encourage innovation and stimulate creativity, and facilitate productive collaborations. Mechanisms include:  Breakthrough Award Levels 1 and 2; Era of hope Scholar Award; Breakthrough Award Level 3; Breakthrough Award Level 4; Innovator Award; and Transformative Breast Cancer Consortium Award.  Deadlines: Varies by mechanism Varies

DOD-CDMRP Lung Cancer Research Program (LCRP)  The vision of the FY22 LCRP is to eradicate deaths and suffering from lung cancer to better the health and welfare of Service Members, Veterans, and the general public. As such, the LCRP will support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, management, and treatment for the control and cure of lung cancer. Mechanisms include: Career Development Award, Concept Award, Clinical Translational Research Partnership Award, Idea Development Award, and Investigator-Initiated Translational Research Award. Deadlines: Varies by mechanism

Varies

DOD-CDMRP Ovarian Cancer Research Program (OCRP)  The mission of the OCRP is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer to enhance the health and well-being of Service Members, Veterans, their family members, and all women impacted by this disease. Mechanisms include: Pilot Award, Proteogenomics Research Award, Ovarian Cancer Academy Award – Early-Career Investigator, and Investigator-Initiated Research Award.  Deadlines: May 2 -  Pre-application; August 5 – Application

Varies

DOD-CDMRP Peer Reviewed Cancer Research Program (PRCRP)  The goal of the PRCRP is to improve quality of life by decreasing the impact of cancer on

active-duty Service Members, their families, Veterans, and the American public. Mechanisms include: Behavioral Health Science Award, Career Development Award, Career Development Award – Virtual Cancer Center Scholar Option, Translational Team Science Award, Convergent Science Cancer Consortium Development Award, Idea Award, and Impact Award. Deadlines: vary by mechanism

Varies

DOD-CDMRP Prostate Cancer Research Program (PCRP)  The PCRP seeks to promote highly innovative, groundbreaking research; high-impact research with near-term clinical relevance; the next generation of prostate cancer investigators through mentored research; and resources that will facilitate translational research. Mechanisms include: Exploration – Hypothesis Development Award, Early Investigator Research Award, Physician Research Award, Translational Science Award, Health Disparity Research Award, Idea Development Award, and Data science Award. Deadlines: vary by mechanism

Varies

DOD-CDMRP Kidney Cancer Research Program (KCRP)  The KCRP’s vision is to eliminate kidney cancer through collaboration and discovery. The KCRP is interested in supporting research and clinical care that addresses the KCRP Overarching Strategic Goals to: (1) increase understanding of the biology of kidney cancer; (2) develop novel therapeutic strategies for the treatment of kidney cancer; (3) improve patient care for kidney cancer; and (4) grow the field and increase collaboration in the area of kidney cancer. Mechanisms include: Concept award; Idea Development Award; Postdoctoral and Clinical Fellowship Award and Translational Research Partnership Award. Deadlines: vary by mechanism

Varies

 DOD-CDMRP Rare Cancers Research Program (RCRP)  The RCRP’s vision is to greatly improve outcomes for people with rare cancers through discovery, community building, and expansion of knowledge across the cancer landscape. The RCRP’s mission is to elevate rare cancers research to enable clinically impactful discoveries for the benefit of active-duty Service Members, Veterans, military beneficiaries, and/or the American public. Focus areas are biology and etiology, research model, and therapy. Mechanisms include: Concept Award, Idea Development Award, and Resource and Community Development Award. Deadlines: Varies by mechanism

Varies

 DOD-CDMRP Pancreatic Cancer Research Program (PCARP)  The goal of the PCARP is to reduce the burden of pancreatic cancer among Service Members, Veterans, their families, and the American public. The mission of the PCARP is to promote rigorous, innovative, high-impact research that leads to earlier pancreatic cancer diagnosis and new therapeutic tools through collaboration. Mechanisms include: Idea Development Award; and Translational Research Partnership Award. Deadlines: July 8 – Pre-application; October 6 - Application

Varies

Damon Runyon Cancer Research Foundation  The Damon Runyon Cancer Research Foundation, we fund high-risk, high-reward cancer research.  The foundation provides a variety of cancer-related funding opportunities. Deadline:  Varies by opportunity

Varies